Spleen volume is a predictor of posthepatectomy liver failure and short-term mortality for hepatocellular carcinoma.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
07 Aug 2023
Historique:
received: 10 05 2023
accepted: 20 07 2023
medline: 8 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

The study aimed at retrospectively assessing the impact of spleen volume (SpV) on the development of posthepatectomy liver failure (PHLF) in patients who underwent hepatectomy for hepatocellular carcinoma (HCC). 152 patients with primary HCC who underwent hepatectomy (sectionectomy or more) were classified into PHLF and non-PHLF groups, and then the relationship between PHLF and SpV was assessed. SpV (cm PHLF was observed in 39 (26%) of the 152 cases. SpV/BSA was significantly higher in the PHLF group, and the postoperative 1-year survival rate was significantly worse in the PHLF group than that in the non-PHLF group (p = 0.044). Multivariable analysis revealed SpV/BSA as a significant independent risk factor for PHLF. Using the cut-off value (160 cm These results suggest SpV as a predictor of PHLF and short-term mortality in patients who underwent hepatectomy for HCC. Moreover, SpV measurement is a simple and potentially useful method for predicting PHLF in patients with HCC.

Sections du résumé

BACKGROUND BACKGROUND
The study aimed at retrospectively assessing the impact of spleen volume (SpV) on the development of posthepatectomy liver failure (PHLF) in patients who underwent hepatectomy for hepatocellular carcinoma (HCC).
METHODS METHODS
152 patients with primary HCC who underwent hepatectomy (sectionectomy or more) were classified into PHLF and non-PHLF groups, and then the relationship between PHLF and SpV was assessed. SpV (cm
RESULTS RESULTS
PHLF was observed in 39 (26%) of the 152 cases. SpV/BSA was significantly higher in the PHLF group, and the postoperative 1-year survival rate was significantly worse in the PHLF group than that in the non-PHLF group (p = 0.044). Multivariable analysis revealed SpV/BSA as a significant independent risk factor for PHLF. Using the cut-off value (160 cm
CONCLUSION CONCLUSIONS
These results suggest SpV as a predictor of PHLF and short-term mortality in patients who underwent hepatectomy for HCC. Moreover, SpV measurement is a simple and potentially useful method for predicting PHLF in patients with HCC.

Identifiants

pubmed: 37548783
doi: 10.1007/s00423-023-03025-w
pii: 10.1007/s00423-023-03025-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450–1462
doi: 10.1056/NEJMra1713263 pubmed: 30970190
Vogel A, Martinelli E (2021) Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Annal Oncol: Official journal of the European Society for Medical Oncology 32:801–805
doi: 10.1016/j.annonc.2021.02.014
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76(3):681–693
Prodeau M, Drumez E, Duhamel A et al (2019) An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy. J Hepatol 71:920–929
doi: 10.1016/j.jhep.2019.06.003 pubmed: 31203152
Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724
doi: 10.1016/j.surg.2010.10.001 pubmed: 21236455
Søreide JA, Deshpande R (2021) Post hepatectomy liver failure (PHLF) – recent advances in prevention and clinical management. Euro J Surg Oncol: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 47:216–224
doi: 10.1016/j.ejso.2020.09.001
Mizuguchi T, Kawamoto M, Meguro M et al (2014) Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today 44:1–10
doi: 10.1007/s00595-013-0534-4 pubmed: 23474700
Garcea G, Maddern GJ (2009) Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 16:145–155
doi: 10.1007/s00534-008-0017-y pubmed: 19110651
Lafaro K, Buettner S, Maqsood H et al (2015) Defining post hepatectomy liver insufficiency: where do we stand? J Gastrointest Surg: official journal of the Society for Surgery of the Alimentary Tract 19:2079–2092
doi: 10.1007/s11605-015-2872-6
Bosch J, García-Pagán JC (2000) Complications of cirrhosis. I. Portal Hypertens J Hepatol 32:141–156
Bolognesi M, Merkel C, Sacerdoti D et al (2002) Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 34:144–150
doi: 10.1016/S1590-8658(02)80246-8
Bae JS, Lee DH, Yoo J et al (2021) Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection. Eur Radiol 31:2461–2471
doi: 10.1007/s00330-020-07313-7 pubmed: 33026503
Peng W, Zhang XY, Li C et al (2019) Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma. Medicine 98:e15458
doi: 10.1097/MD.0000000000015458 pubmed: 31045820 pmcid: 6504243
Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304
doi: 10.1002/ssu.2980090404 pubmed: 8210909
Cherrick GR, Stein SW, Leevy CM et al (1960) Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Investig 39:592–600
doi: 10.1172/JCI104072 pubmed: 13809697 pmcid: 293343
Ohkura Y, Mizuno S, Kishiwada M et al (2014) Benefit of technetium-99m galactosyl human serum albumin scintigraphy instead of indocyanine green test in patients scheduled for hepatectomy. Hepatol Res: the official journal of the Japan Society of Hepatology 44:E118-128
doi: 10.1111/hepr.12248
Ohshima S (2014) Volume analyzer SYNAPSE VINCENT for liver analysis. J Hepatobiliary Pancreat Sci 21:235–238
doi: 10.1002/jhbp.81 pubmed: 24520049
McCormick PA, Murphy KM (2000) Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Bailliere’s Best Pract Res Clin Gastroenterol 14:1009–1031
doi: 10.1053/bega.2000.0144
Kohler A, Moller PW, Frey S et al (2019) Portal hyperperfusion after major liver resection and associated sinusoidal damage is a therapeutic target to protect the remnant liver. Am J Physiol Gastrointest Liver Physiol 317:G264-g274
doi: 10.1152/ajpgi.00113.2019 pubmed: 31216172
Forbes SJ, Newsome PN (2016) Liver regeneration – mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol 13:473–485
doi: 10.1038/nrgastro.2016.97 pubmed: 27353402
Eipel C, Abshagen K, Vollmar B (2012) Small-for-size: experimental findings for liver surgery. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 83:238–246
doi: 10.1007/s00104-011-2179-4 pubmed: 22012419
Niiya T, Murakami M, Aoki T et al (1999) Immediate increase of portal pressure, reflecting sinusoidal shear stress, induced liver regeneration after partial hepatectomy. J Hepatobiliary Pancreat Surg 6:275–280
doi: 10.1007/s005340050118 pubmed: 10526063
Sato Y, Koyama S, Tsukada K et al (1997) Acute portal hypertension reflecting shear stress as a trigger of liver regeneration following partial hepatectomy. Surg Today 27:518–526
doi: 10.1007/BF02385805 pubmed: 9306545
Hirao H, Ito T, Kadono K et al (2021) Donor hepatic occult collagen deposition predisposes to peritransplant stress and impacts human liver transplantation. Hepatology (Baltimore, MD) 74:2759–2773
doi: 10.1002/hep.32030 pubmed: 34170562
Garcea G, Ong SL, Maddern GJ (2009) Predicting liver failure following major hepatectomy. Dig Liver Dis: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41:798–806
doi: 10.1016/j.dld.2009.01.015
Lam CM, Fan ST, Lo CM et al (1999) Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86:1012–1017
doi: 10.1046/j.1365-2168.1999.01204.x pubmed: 10460635
Satoh K, Yamamoto Y, Nishiyama Y et al (2003) 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 17:61–67
doi: 10.1007/BF02988261 pubmed: 12691132
Redaelli CA, Dufour JF, Wagner M et al (2002) Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235:77–85
doi: 10.1097/00000658-200201000-00010 pubmed: 11753045 pmcid: 1422398
Lorf T, Schnitzbauer AA, Schaefers SK et al (2008) Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection. Hepatogastroenterology 55:539–543
pubmed: 18613404
Katsuramaki T, Mizuguchi T, Kawamoto M et al (2006) Assessment of nutritional status and prediction of postoperative liver function from serum apolioprotein A-1 levels with hepatectomy. World J Surg 30:1886–1891
doi: 10.1007/s00268-005-0590-z pubmed: 16983478
Yachida S, Wakabayashi H, Kokudo Y et al (2000) Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg 24:359–364
doi: 10.1007/s002689910057 pubmed: 10658073
Poon RT, Fan ST, Lo CM et al (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236:602–611
doi: 10.1097/00000658-200211000-00010 pubmed: 12409666 pmcid: 1422618
Wong JS, Wong GL, Chan AW et al (2013) Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes. Ann Surg 257:922–928
doi: 10.1097/SLA.0b013e318269d2ec pubmed: 23001077
Sunagawa Y, Yamada S, Kato Y et al (2021) Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci 28:86–94
doi: 10.1002/jhbp.833 pubmed: 33052632
Yokoyama Y, Nishio H, Ebata T et al (2010) Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg 97:1260–1268
doi: 10.1002/bjs.7084 pubmed: 20602507

Auteurs

Takahiro Ito (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan. Itotakahiro@med.mie-u.ac.jp.

Akihiro Tanemura (A)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Toru Kuramitsu (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Taichi Murase (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Benson Kaluba (B)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Daisuke Noguchi (D)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Tekehiro Fujii (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Takuya Yuge (T)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Koki Maeda (K)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Aoi Hayasaki (A)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Kazuyuki Gyoten (K)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Yusuke Iizawa (Y)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Yasuhiro Murata (Y)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Naohisa Kuriyama (N)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Masashi Kishiwada (M)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Shugo Mizuno (S)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH